ArticleThe American journal of case reports2026
Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Post-radiation angiosarcoma (PRA) is a rare, invasive mesenchymal tumor associated with prior cancer radiotherapy. The diagnostic criteria for PRA include a history of radiation exposure, the development of a new malignant tumor with a long latency period within the irradiated field, and a histological type different from that of the primary malignancy if radiation was administered for the original cancer. Although PRA can arise in any part of the body, it most commonly occurs in the skin. Only a few cases of vascular sarcoma secondary to radiotherapy for cervical cancer have been reported, and reports of peritoneal angiosarcoma following pelvic irradiation for cervical cancer are exceedingly rare. CASE REPORT A 69-year-old woman presented with abdominal discomfort 22 years after receiving radiation therapy for cervical cancer. Imaging and laboratory evaluations failed to reveal a definitive cause, leading to suspicion of recurrence or metastasis of cervical cancer. The patient underwent surgical exploration; postoperative histopathology with immunohistochemistry confirmed the diagnosis of angiosarcoma. She subsequently received 4 cycles of chemotherapy with paclitaxel, carboplatin, and bevacizumab. However, 4 months after surgery, computed tomography revealed new lesions in the abdominal cavity and intestinal wall. The patient ultimately died of disease progression. CONCLUSIONS This case illustrates a rare instance of peritoneal angiosarcoma occurring after radiotherapy for cervical cancer. Clinicians should maintain a high index of suspicion for secondary malignancies in long-term cancer survivors presenting with new-onset peritoneal symptoms. Secondary peritoneal angiosarcoma should be considered in patients with prior radiation exposure and peritoneal involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.